The MGMT gene promoter status was analyzed in 19 patients with GBM, one with neuroepithelial tumor with EP300::BCOR(L1) fusion, and one with astrocytoma CNS WHO grade 2. This evidence concerns the gene MGMT and neuroepithelial neoplasm.